Rockefeller Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Rockefeller Capital Management’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,196	Closed	-$247K	–	1799
2025 Q1	$247K	Buy	+22,196	New	+$245K	﹤0.01%	1623
2023 Q3	–	Sell	-12,000	Closed	-$135K	–	1851
2023 Q2	$135K	Hold	12,000	–	–	﹤0.01%	1737
2023 Q1	$126K	Hold	12,000	–	–	﹤0.01%	1878
2022 Q4	$116K	Buy	12,000 +1,000	+9%	+$11.3K	﹤0.01%	1962
2022 Q3	$135K	Hold	11,000	–	–	﹤0.01%	1836
2022 Q2	$112K	Buy	11,000 +6,500	+144%	+$71.8K	﹤0.01%	1884
2022 Q1	$57K	Buy	4,500 +3,500	+350%	+$53.5K	﹤0.01%	2245
2021 Q4	$20K	Buy	+1,000	New	+$20.2K	﹤0.01%	2656

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rockefeller Capital Management's ENFN Position: Q2 2025 in Review

Rockefeller Capital Management sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 22,196 shares — an estimated $247K sold.

Rockefeller Capital Management first reported a position in ENFN in Q4 2021 and held it in 8 quarters. The position peaked at $247K in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Rockefeller Capital Management reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Rockefeller Capital Management sold 22,196 Enfusion, Inc. shares in Q2 2025, an estimated $247K.
Rockefeller Capital Management first reported a position in Enfusion, Inc. in Q4 2021 and held it in 8 quarters.
Rockefeller Capital Management's Enfusion, Inc. position peaked at $247K in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Rockefeller Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.